Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisation
Sign Up to like & getrecommendations! Published in 2024 at "BMJ Case Reports"
DOI: 10.1136/bcr-2023-258516
Abstract: Neuroendocrine tumours (NETs) are rare cancers which often carry significant morbidity and mortality, frequently related to burden of liver metastases. Hyperammonaemia and subsequent hepatic encephalopathy carries a poor prognosis and has been described in these… read more here.
Keywords: nucleotide therapy; peptide receptor; receptor radio; hyperammonaemic encephalopathy ... See more keywords